Skip to main content
. 2022 Aug 5;13:911810. doi: 10.3389/fphar.2022.911810

TABLE 2.

Outcomes of secondary endpoints.

Outcomes Types of Invention Subgroup Heterogeneity Overall Effect Statistical Studies (N) Participants(N) Figures
I2 (%) p MD 95%CI p Significant Method
TJC-28 IGU MTX 70 0.04 -2.17 [-2.92, -1.42] <0.00001 Yes Random 3 237 S1
IGU + MTX MTX 0 0.44 -2.54 [-2.69, -2.38] <0.00001 Yes Random 5 427 S3
MTX + LEF 32 0.22 -0.14 [-0.34,0.06] 0.16 No 4 413
MTX + HCQ 0 -0.76 [-0.94, -0.58] <0.00001 Yes 1 146
MTX + TGs 37 0.21 -1.78 [-2.33, -1.23] <0.00001 Yes 2 160
Summary 96 <0.00001 -1.40 [-1.98, -0.81] <0.0001 Yes 12 1146
SJC-28 IGU MTX 90 <0.0001 -1.22 [-1.40, -1.04] <0.00001 Yes Random 3 237 S1
IGU + MTX MTX 5 0.38 -2.98 [-3.11, -2.85] <0.00001 Yes Random 5 427 S4
MTX + LEF 73 0.01 -0.09 [-0.36, 0.18] 0.50 No 4 413
MTX + HCQ 0 -1.30 [-1.67, -0.93] <0.00001 Yes 1 146
MTX + TGs 55 0.14 -1.99 [-2.66, -1.33] <0.00001 Yes 2 160
Summary 99 <0.00001 -1.84 [-2.81, -0.87] 0.0002 Yes 12 1146
VAS IGU MTX 0 0.45 -5.61 [-7.12, -4.11] <0.00001 No Fixed 3 234 S2
IGU + MTX MTX 0 -5.30 [-7.71, -2.89] <0.0001 Yes Random 1 60 S5
MTX + TGs 0 -0.21 [-1.08, 0.06] 0.64 No 1 60
Summary 100 <0.00001 -2.63 [-7.61, 2.36] 0.30 No 2 180
PGA IGU MTX 0 0.59 -2.73 [-3.52, -1.95] <0.00001 Yes Fixed 3 167 S2
IGU + MTX MTX 0 0.74 -12.77 [-13.40, -12.13] <0.00001 Yes Fixed 4 293 S5
EGA IGU MTX 0 0.85 -3.27 [-3.95, -2.59] <0.00001 Yes Fixed 3 234 S2
IGU + MTX MTX 73 0.01 -5.08 [-9.93, -0.82] <0.00001 Yes Random 4 275 S5
HAQ IGU MTX 0 0.89 0.00 [-0.01, 0.01] 0.96 No Fixed 4 294 S2
IGU + MTX MTX 88 <0.00001 -0.17 [-0.50, 0.17] 0.34 No Random 4 260 S5
MTX + LEF 0 0.00 [-0.26, 0.26] 1.00 No 1 144
Summary 85 <0.0001 -0.13 [-0.41, 0.14] 0.34 No 5 404
ESR IGU MTX 59 0.04 -6.34 [-6.89, -5.79] <0.00001 Yes Random 5 357 S1
IGU + MTX MTX 96 <0.00001 -15.27 [-20.31, -10.23] <0.00001 Yes Random 11 815 S6
MTX + LEF 74 0.02 -2.37 [-9.64,4.90] 0.52 No 3 324
MTX + HCQ 0 -6.61 [-8.17, -5.05] <0.00001 Yes 1 146
MTX + TGs 52 0.12 -5.91 [-8.86, -2.95] <0.0001 Yes 3 220
Summary 97 <0.00001 -10.98 [-15.01, -6.96] <0.00001 Yes 18 1505
CRP IGU MTX 96 <0.00001 -5.91 [-9.45, -2.37] 0.001 Yes Random 5 357 S1
IGU + MTX MTX 95 <0.00001 -10.87 [-14.31, -7.43] <0.00001 Yes Random 12 875 S7
MTX + LEF 44 0.18 2.15 [-3.78,8.09] 0.48 No 2 199
MTX + HCQ 93 0.0001 -4.17 [-6.75, -1.58] 0.002 Yes 2 206
MTX + TGs 0 0.82 -2.56 [-4.14, -0.98] 0.001 Yes 2 120
Summary 97 <0.00001 -7.75 [-10.41, -5.08] <0.00001 Yes 18 1400
Anti-CCP IGU MTX 0 -13.00 [-18.40, -7.60] <0.00001 Yes Fixed 1 53 S2
IGU + MTX MTX 0 0.77 -17.51 [-22.66, -12.37] <0.00001 Yes Fixed 3 175 S8
MTX + LEF 0 -125 [-277.88, 27.88] 0.11 No 1 142
MTX + TGs 0 -10.03 [-78.49, 58.43] 0.77 No 1 60
Summary 0 0.65 -17.59 [-22.72, -12.46] <0.00001 Yes 5 377
RF IGU MTX 0 0.35 -3.03 [-7.69,1.63] 0.20 No Fixed 2 123 S2
IGU + MTX MTX 38 0.18 -32.11 [-34.54, -29.68] <0.00001 Yes Random 4 231 S9
MTX + HCQ 0 -20.5 [-24.18, -16.82] <0.00001 Yes 1 146
MTX + TGs 0 -354.4 [-435.91, -272.89] <0.00001 Yes 1 60
Summary 95 <0.00001 -31.66 [-40.06, -23.26] <0.00001 Yes 6 437
Morning stiffness IGU MTX 98 <0.00001 -0.31 [-0.35, -0.28] <0.00001 Yes Random 2 174 S1
IGU + MTX MTX 99 <0.00001 -4.05 [-5.00, -3.09] <0.00001 Yes Random 8 686 S10
MTX + LEF 41 0.19 -0.78 [-4.00,2.44] 0.63 No 2 205
MTX + TGs 0 -0.46 [-0.80, -0.12] 0.009 Yes 1 60
Summary 98 <0.00001 -1.21 [-1.70, -0.73] <0.00001 Yes 10 951